Leucine-rich diet supplementation modulates foetal muscle protein metabolism impaired by Walker-256 tumour

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Cruz, Bread ^a   Gomes Marcondes, Maria C C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Foetal protein metabolism; Leucine; Nutritional supplementation; Proteasome; Walker tumour

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CATALASE; CATHEPSIN; CATHEPSIN H; CHYMOTRYPSIN; GLUCOSE; GLUTATHIONE TRANSFERASE; LEUCINE; MALONALDEHYDE; MUSCLE PROTEIN; OXIDOREDUCTASE; PHENYLALANINE; PLASMA PROTEIN; SUPEROXIDE DISMUTASE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; FETUS; FETUS WEIGHT; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; LIPID PEROXIDATION; MALE; MOTHER; MUSCLE RESECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN DIET; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RAT; TUMOR GROWTH; WALKER CARCINOMA;

ANIMALS; CARCINOMA 256, WALKER; DIETARY SUPPLEMENTS; FEMALE; FETUS; LEUCINE; MUSCLE PROTEINS; MUSCLE, SKELETAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR;

EID: 84891960443     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-2     Document Type: Article

References (54)

1. Pavlidis N, Pentheroudakis G. The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev 2005, 31(6):439-447. 10.1016/j.ctrv.2005.04.010, 15946802.
2. Azim HA, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors. Cancer Treat Rev 2010, 36(2):110-121. 10.1016/j.ctrv.2009.11.004, 20018452.
3. Toledo MT, Ventrucci G, Marcondes MCCG. Cancer during pregnancy alters the activity of rat placenta and enhances the expression of cleaved PARP, cytochrome-c and caspase 3. BMC Cancer 2006, 6:168-177. 10.1186/1471-2407-6-168, 1534057, 16800886.
4. Gomes-Marcondes MCC, Cury L, Curi R. Consequences of Walker 256 tumour growth for the placental/foetal development in rats. Cancer Res Ther Control 1998, 5:277-283.
5. Ventrucci G, Mello MAR, Gomes-Marcondes MCC. Effect of a leucine-supplemented diet on body composition changes in pregnant rats bearing walker 256 tumor. Braz J Med Biol Res 2001, 34(3):333-338. 10.1590/S0100-879X2001000300006, 11262583.
6. Ventrucci G, Mello MAR, Gomes-Marcondes MCC. Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats fed a leucine-rich diet. Endocr Relat Cancer 2004, 11(4):887-895. 10.1677/erc.1.00828, 15613461.
7. Viana LR, Gomes-Marcondes MC. Leucine-rich diet improves the serum amino acid profile and body composition of fetuses from tumor-bearing pregnant mice. Biol Reprod 2013, 88(5):121. 10.1095/biolreprod.112.107276, 23553429.
8. Ventrucci G, Mello MAR, Gomes-Marcondes MCC. Leucine-rich diet alters the eukaryotic translation initiation factors expression in skeletal muscle of tumour-bearing rats. BMC Cancer 2007, 7:42-52. 10.1186/1471-2407-7-42, 1832207, 17341295.
9. Emery PW. Cachexia in experimental models. Nutrition 1999, 15(7-8):600-603.
10. Bennani-Baiti N, Walsh D. Animal models of the cancer anorexia-cachexia syndrome. Support Care Cancer 2011, 19(9):1451-1463. 10.1007/s00520-010-0972-0, 20714754.
11. Fowden AL, Forhead AJ, Ousey JC. Endocrine adaptations in the foal over the perinatal period. Equine Vet J 2012, 44:130-139.
12. Perkins AV. Endogenous anti-oxidants in pregnancy and preeclampsia. Aust N Z J Obstet Gynaecol 2006, 46(2):77-83. 10.1111/j.1479-828X.2006.00532.x, 16638026.
13. Mantovani G, Madeddu C, Maccio A, Gramignano G, Lusso MR, Massa E, Astara G, Serpe R. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 2004, 13(10):1651-1659.
14. Garlick PJ. The role of leucine in the regulation of protein metabolism. J Nutr 2005, 135(6):1553s-1556s.
15. Ventrucci G, Mello MA, Gomes-Marcondes MC. Leucine-rich diet alters the eukaryotic translation initiation factors expression in skeletal muscle of tumour-bearing rats. BMC Cancer 2007, 7:42. 10.1186/1471-2407-7-42, 1832207, 17341295.
16. Norton LE, Layman DK. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. J Nutr 2006, 136(2):533s-537s.
17. Choudry HA, Pan M, Karinch AM, Souba WW. Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. J Nutr 2006, 136(1):314s-318s.
18. Kado K, Forsyth A, Patel PR, Schwartz JA. Dietary supplements and natural products in breast cancer trials. Front Biosci (Elite Ed) 2012, 4:546-567.
19. Hardy ML. Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin North Am 2008, 22(4):581-617. vii, 10.1016/j.hoc.2008.04.012, 18638690.
20. Ishikawa T. Early administration of branched-chain amino acid granules. World J Gastroenterol 2012, 18(33):4486-4490. 10.3748/wjg.v18.i33.4486, 3435773, 22969221.
21. Sun LC, Shih YL, Lu CY, Hsieh JS, Chuang JF, Chen FM, Ma CJ, Wang JY. Randomized, controlled study of branched chain amino acid-enriched total parenteral nutrition in malnourished patients with gastrointestinal cancer undergoing surgery. Am Surg 2008, 74(3):237-242.
22. Barker DJP. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 1997, 13(9):807-813. 10.1016/S0899-9007(97)00193-7, 9290095.
23. Reeves PG, Nielsen FH, Fahey GC. Ain-93 purified diets for laboratory rodents - final report of the American institute of nutrition Ad Hoc writing committee on the reformulation of the Ain-76a rodent diet. J Nutr 1993, 123(11):1939-1951.
24. Ventrucci G, Silva LGR, Mello MAR, Marcondes MCCG. Effects of a leucine-rich diet on body composition during nutritional recovery in rats. Nutrition 2004, 20(2):213-217. 10.1016/j.nut.2003.10.014, 14962689.
25. Gomes-Marcondes MCC, Ventrucci G, Toledo MT, Cury L, Cooper JC. A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats. Braz J Med Biol Res 2003, 36(11):1589-1594. 10.1590/S0100-879X2003001100017, 14576914.
26. Salomao EM, Gomes-Marcondes MCC. Light aerobic physical exercise in combination with leucine and/or glutamine-rich diet can improve the body composition and muscle protein metabolism in young tumor-bearing rats. J Physiol Biochem 2012, 68(4):493-501. 10.1007/s13105-012-0164-0, 22460363.
27. Ventrucci G, de Mello MA, Gomes-Marcondes MC. Effects of leucine supplemented diet on intestinal absorption in tumor bearing pregnant rats. BMC Cancer 2002, 2:7. 10.1186/1471-2407-2-7, 111198, 11955290.
28. Vary TC, Jefferson LS, Kimball SR. Amino acid-induced stimulation of translation initiation in rat skeletal muscle. Am J Physiol Endocrinol Metab 1999, 277(6):E1077-E1086.
29. Fedele MJ, Vary TC, Farrell PA. Plasticity in skeletal, cardiac, and smooth muscle - selected contribution: IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic rats. J Appl Physiol 2001, 90(3):1166-1173.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193(1):265-275.
31. Lorite MJ, Thompson MG, Drake JL, Carling G, Tisdale MJ. Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 1998, 78(7):850-856. 10.1038/bjc.1998.592, 2063122, 9764574.
32. Waalkes TP, Udenfriend S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 1957, 50(5):733-736.
33. Barrett AJ. Fluorimetric assays for Cathepsin-B and Cathepsin-H with methylcoumarylamide substrates. Biochem J 1980, 187(3):909-912. 1162479, 6897924.
34. Jiang ST, Wang JH, Chang T, Chen CS. A continuous method for measuring calpain activity. Anal Biochem 1997, 244(2):233-238. 10.1006/abio.1996.9872, 9025939.
35. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases - first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249(22):7130-7139.
36. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970, 34(1):30. 10.1016/0003-2697(70)90083-7, 5440916.
37. Martins MJ, Negrao MR, Hipolito-Reis C. Alkaline phosphatase from rat liver and kidney is differentially modulated. Clin Biochem 2001, 34(6):463-468. 10.1016/S0009-9120(01)00255-7, 11676975.
38. Gomes-Marcondes MCC, Tisdale MJ. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett 2002, 180(1):69-74. 10.1016/S0304-3835(02)00006-X, 11911972.
39. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949, 177(2):751-766.
40. Meulemans O. Determination of total protein in spinal fluid with sulphosalicylic acid and trichloroacetic acid. Clin Chim Acta 1960, 5(5):757-761. 10.1016/0009-8981(60)90020-6, 13769924.
41. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol 1969, 22(2):246.
42. Gad SC. Statistic for toxicologists. Principles and Methods of toxicology, 4th edition 2009, 221-274. New York: Raven Press.
43. Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol 2010, 26(2):146-151. 10.1097/MOG.0b013e3283347e77, 19918173.
44. Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia-pathophysiology and management. J Gastroenterol 2013, 48(5):574-594. 10.1007/s00535-013-0787-0, 3698426, 23512346.
45. Yano CL, Ventrucci G, Field WN, Tisdale MJ, Gomes-Marcondes MC. Metabolic and morphological alterations induced by proteolysis-inducing factor from walker tumour-bearing rats in C2C12 myotubes. BMC Cancer 2008, 8:24. 10.1186/1471-2407-8-24, 2266935, 18226207.
46. Liu W, Glunde K, Bhujwalla ZM, Raman V, Sharma A, Phang JM. Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res 2012, 72(14):3677-3686. 10.1158/0008-5472.CAN-12-0080, 3399032, 22609800.
47. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012, 16(2):153-166. 10.1016/j.cmet.2012.06.011, 22795476.
48. Hay WW. Recent observations on the regulation of fetal metabolism by glucose. J Physiol 2006, 572(1):17-24. 1779657, 16455683.
49. Cetin I, Antonazzo P. The role of the placenta in intrauterine growth restriction (IUGR). Z Geburtshilfe Neonatol 2009, 213(3):84-88. 10.1055/s-0029-1224143, 19536707.
50. Toledo MT, Ventrucci G, Gomes-Marcondes MC. Increased oxidative stress in the placenta tissue and cell culture of tumour-bearing pregnant rats. Placenta 2011, 32(11):859-864. 10.1016/j.placenta.2011.08.009, 21903263.
51. Toledo MT, Gomes Marcondes MC. Placental glycogen metabolism changes during walker tumour growth. Placenta 2004, 25(5):456-462. 10.1016/j.placenta.2003.11.005, 15081640.
52. Carbo N, Lopezsoriano FJ, Argiles JM. Administration of tumor-necrosis-factor-alpha results in a decreased placental-transfer of amino-acids in the rat. Endocrinology 1995, 136(8):3579-3584.
53. Zhang GH, Jin BW, Li YP. C/EBP beta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J 2011, 30(20):4323-4335. 10.1038/emboj.2011.292, 3199382, 21847090.
54. Aversa Z, Bonetto A, Costelli P, Minero VG, Penna F, Baccino FM, Lucia S, Fanelli FR, Muscaritoli M. beta-hydroxy-beta-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Int J Oncol 2011, 38(3):713-720.